BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31378881)

  • 1. Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer.
    You Q; Shi HY; Gong CF; Tian XY; Li S
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6429-6435. PubMed ID: 31378881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p.
    Kong L; Zhang C
    Cancer Cell Int; 2020; 20():370. PubMed ID: 32774164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA DLX6-AS1 functions as a competing endogenous RNA for miR-577 to promote malignant development of colorectal cancer.
    Zhou FR; Pan ZP; Shen F; Huang LQ; Cui JH; Cai K; Guo XL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3742-3748. PubMed ID: 31115000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.
    Li D; Tang X; Li M; Zheng Y
    J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA DLX6-AS1/miR-141-3p axis regulates osteosarcoma proliferation, migration and invasion through regulating Rab10.
    Guo Q; Sun H; Zheng K; Yin S; Niu J
    RSC Adv; 2019 Oct; 9(58):33823-33833. PubMed ID: 35528911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.
    Zhang HY; Xing MQ; Guo J; Zhao JC; Chen X; Jiang Z; Zhang H; Dong Q
    Cancer Cell Int; 2019; 19():313. PubMed ID: 31787850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of long noncoding RNA DLX6-AS1 promotes cell growth and metastasis in esophageal squamous cell carcinoma via targeting miR-577.
    Wu SB; Wang HQ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1195-1201. PubMed ID: 32096208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer.
    Huang K; Fan WS; Fu XY; Li YL; Meng YG
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2353-2359. PubMed ID: 30964159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of long noncoding RNA DLX6-AS1 inhibits migration and invasion of thyroid cancer cells by upregulating UPF1.
    Zhong ZB; Wu YJ; Luo JN; Hu XN; Yuan ZN; Li G; Wang YW; Yao GD; Ge XF
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10867-10873. PubMed ID: 31858555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.
    An Y; Chen XM; Yang Y; Mo F; Jiang Y; Sun DL; Cai HH
    Cancer Cell Int; 2018; 18():143. PubMed ID: 30250401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
    Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
    Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA TTN-AS1 promotes breast cancer cell migration and invasion via sponging miR-140-5p.
    Xue J; Zhang Z; Li X; Ren Q; Wang Q
    Oncol Lett; 2020 Feb; 19(2):1255-1260. PubMed ID: 31966055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

  • 17. LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c.
    Yang Q; Sun J; Ma Y; Zhao C; Song J
    Am J Transl Res; 2019; 11(11):7009-7017. PubMed ID: 31814904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA
    Sun W; Zhang L; Yan R; Yang Y; Meng X
    Onco Targets Ther; 2019; 12():3945-3954. PubMed ID: 31190891
    [No Abstract]   [Full Text] [Related]  

  • 19. LncRNA OIP5-AS1 upregulates snail expression by sponging miR-34a to promote ovarian carcinoma cell invasion and migration.
    Jiang X; Ye Z; Jiang Y; Yu W; Fang Q
    Biol Res; 2020 Oct; 53(1):49. PubMed ID: 33092644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulatory network of lncRNA DLX6-AS1/miR-149-5p/ERP44 is possibly related to the progression of preeclampsia.
    Liu R; Wang X; Yan Q
    Placenta; 2020 Apr; 93():34-42. PubMed ID: 32250737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.